A device for treating a snake bite wound that utilizes a hypodermic tube with a curvature that is similar to a typical snake fang whereby the hypodermic tube on one end comprises a smooth bulbous tip with at least one opening and a vacuum source is attached to the other end of the hypodermic tube. The tip is inserted into a snake bite wound, and due to the curved shape of the hypodermic tube, the tip and the tube then follow the curved shape of the snake bite wound without damaging any of the tissue surrounding the snake bite canal. The vacuum source then extracts any venom that is present from the wound. The device also enables medicine to be injected into the wounded area to treat the wound.
|
17. A method of delivering medication to a snake bite wound comprising the steps of:
inserting a hollow tip of a device into the snake bite wound until the hollow tip enters a venom vacuole within the snake bite wound whereby the hollow tip is connected to one end of a curved hypodermic tube;
injecting the medication into a second end of the hypodermic tube such that the medication moves from the hypodermic tube into the venom vacuole through multiple openings in the hollow tip.
11. A method of extracting venom from a snake bite wound comprising the steps of:
inserting a hollow tip of a device into the snake bite wound until the hollow tip enters a venom vacuole within the snake bite wound whereby the hollow tip is connected to one end of a curved hypodermic tube;
applying a vacuum source to a second end of the hypodermic tube such that the vacuum source draws a venom deposit from the venom vacuole into the hollow tip through multiple openings in the hollow tip.
1. A device for both extracting venom from a snake bite wound and delivering medicine to the wound comprising:
a hypodermic tube;
a hollow tip;
the hollow tip comprises a diameter that is different than the diameter of the hypodermic tube and is integrated with one end of the hypodermic tube and;
the hollow tip further comprises multiple openings such that a fluid flows through the openings either from, or into the hypodermic tube;
the hypodermic tube having a curvature that enables the hypodermic tube to follow a curved path of a snake bite wound when the tip of the device is inserted into the snake bite wound.
2. The device of
7. The device of
18. The method of
|
The present invention relates generally to the treatment of snake bites, but may be useful in treating other types of venomous bites and in particular, the need to treat snake bites by both extracting snake venom from a victim's wound, and injecting medication such as antivenin or antibiotics to effectively treat the Patient to help reduce the possibility of death, tissue death, discomfort, infection, or disfigurement.
The prior art contains devices that allow people to extract snake venom from a wounded area. For example, the invention described in U.S. Pat. No. 3,742,954 includes a lance and telescopically-mounted poison extractor tube in a single unit. The lance includes two blades mounted on a spring member that is released by a trigger arrangement, which allows the lance to cut into a person's flesh at a given length. Once the lance is inserted to open the wounded area, the lance is then removed so that the poison may be extracted. This is accomplished by placing the tube over the wound so that a person can create suction by sucking air through a hole on one side of the tube.
Another example of the representative prior art is described in U.S. Pat. No. 2,539,846. The patent discloses a pump with a piston construction connected to a nozzle with a small open tip whereby the tip is placed over the wounded area and the pumping mechanism extracts any snake venom from within the flesh.
In a similar manner, U.S. Pat. No. 5,387,203 discloses a device that uses a syringe-like structure for extracting pus, blood, and other materials from beneath a person's skin. The device uses a plunger that is pulled out through a tube to create a vacuum when the tube is placed securely on top of the person's skin. The vacuum pulls the skin area into the tube so that it can be punctured by a piercing element, thereby allowing the blood, pus, or other materials to be extracted from the skin area and into the tube. U.S. Pat. No. 3,625,217 operates in a similar fashion without the use of a piercing device.
Finally, it is also generally known that a standard hypodermic needle and syringe may be used to pierce and extract the venom directly from the wounded area.
Advantageously, all of these devices enable a snake bite victim to treat the wound by extracting the snake's venom using various forms of simple suction and lancing techniques.
When a snake bites its victim, the trauma to the affected area can be severe and requires immediate treatment to minimize tissue and nerve damage, the spread of the poisonous venom to other areas of the body, and prevent the victim from losing consciousness or even dying. The problem is further exacerbated when a victim is in a wilderness area where competent medical treatment is either primitive or non-existent.
A typical snakebite will create a venom cavity or vacuole within the tissue. If the toxin in the venom cavity is left untreated, the body will eventually absorb the venom into the surrounding tissue and the venom will enter the blood or lymph streams or both. In these cases, the quick and efficient removal of the venom from the wound can be the difference between life and death.
While the prior art devices are designed to remove the venom directly from the wound, these devices are not efficient, and many times, not effective at treating a snake bite. In particular, the devices that utilize vacuum suction techniques often create bulging and hemorrhaging to the entry site of the wound. As a result, the dermal and subcutaneous tissue layers, as well as the muscle tissues damaged by the vacuum can lead to edema. This often will close the wound's opening and prevent any opportunity to extract venom from the subcutaneous tissue.
Furthermore, because snake fangs are curved, they do not pierce tissue in a straight line. When a standard straight hypodermic needle and syringe are used to extract venom from the wounded area, the needle cannot track the curved shape of the wound and is too sharp to follow the wound cavity. This means that while the needle may ultimately reach the venom cavity, the needle will likely inflict damage to the surrounding area. By doing so, the surrounding tissue will likely absorb the venom more quickly. Also, because the depth of a snake bite varies, it is also difficult to determine how deep to insert a standard needle, and there is no way to be certain the needle opening is ideally located in the center of the wound cavity.
In addition to inflicting damage to the surrounding tissue, the prior art snake bite treatments offer no way to deliver high concentrations of medicine such as antivenin or antibiotics directly into the tissue immediately surrounding the wound without further damaging the tissue or creating other pathways for the venom to enter the blood stream. Initially, the bite site is where the highest concentration of venom exists. The need to get the medicine to the area of highest venom concentrations as quickly as possible is crucial. A hemotoxic venom will quickly cause the tissue nearest the wound to begin necrosis or coagulopathy. If antivenin, antibiotics, or other medications are not delivered quickly to the wound, a number of serious complications may arise such as ecchymosis, rhabdomyolysis leading to hyperkalemia or possibly severe edema causing compartment syndrome. One treatment for compartment syndrome requires cutting the skin and muscle fascia lengthwise down the limb to allow the muscles to expand consistent with the blood flow. This type of treatment inevitably leaves an unsightly scar. In addition, some patients require high doses of antivenin to counteract the effects of the venom especially in localized areas, it may induce a condition called serum sickness which may cause signs and symptoms consistent with an allergic reaction, which may sometimes be severe. The treatment protocol is to give only as much antivenin as is required.
These problems and shortcomings of the prior art are overcome with the present invention. The invention provides a way to both effectively and efficiently extract snake venom from a snake bite wound and deliver the necessary medicinal substances without damaging the surrounding tissue. The preferred embodiment of the invention accomplishes this by using a hypodermic tube connected to a vacuum source such that the tube has a curvature that conforms, or is shaped to the curvature of a snake fang. Preferably, the tube comprises either a metal hypodermic needle or a plastic catheter. The vacuum source may comprise some form of a syringe, vacuum bottle, or any device capable of generating a gentle suction. The tip should preferably be smooth and bulbous with one or more openings so that the tube can slide easily into the wound canal and reach the venom cavity directly without damaging the surrounding tissue. When the tip reaches the bottom of the venom cavity, the tip's smooth texture and bulbous shape would preclude the device from being inserted any further. The vacuum source can then draw the venom out of the cavity through the openings in the tip, flow up the tube, and into a reservoir.
The tube also provides a way to deliver medication directly to the wound. Presuming the tube is inserted in the same manner as just described; the syringe, intravenous dripper (I.V.) or pump delivery system can deliver the medication directly to the wounded area and be absorbed through the same tissue pathways as the venom. The invention gives the added advantage of immediately neutralizing the venom's toxicity at the exact point of delivery, before the venom can migrate and necrotize other tissues within the body. One benefit of the process is the potential reduction in the amount of antivenin required to treat the patient, thereby reducing the risk of serum sickness.
The description of the invention which follows, together with the accompanying drawings should not be construed as limiting the invention to the example shown and described, because those skilled in the art to which this invention appertains will be able to devise other forms thereof within the ambit of the appended claims.
By way of one example of many to serve as background in understanding the preferred embodiment of the present invention, as shown in
As shown in
After extracting the venom 140 from the venom vacuole 60, the device 10 may be used to deliver medicines to the venom vacuole 60. To do so, medicine such as antivenin or antibiotics in liquid form 115 are placed in the syringe container, I.V. or medical grade pump 110. The plunger 120 is then pushed down thereby forcing the liquid 115 from the syringe 100 into the delivery tube 90 and into the tube 20. Once in the tube 20, the medicine 115 travels into the tip 40 and out the holes 30 where it reaches the venom vacuole 60. It is understood by those of ordinary skill in the art that the medicine 115 will travel similar pathways to the venom to be absorbed by the surrounding tissue 70 where it will immediately treat the envenomated area.
A more detailed view of the tip of the needle is shown in
While the apparatus for practicing the within inventive method, as well as said method herein shown and disclosed in detail is fully capable of attaining the objects and providing the advantages hereinbefore stated, it is to be understood that it is merely illustrative of the presently preferred embodiment of the invention and that no limitations are intended to the detail of construction or design herein shown other than as defined in the appended claims.
Although the invention has been described in detail with reference to one or more particular preferred embodiments, persons possessing ordinary skill in the art to which this invention pertains will appreciate that various modifications and enhancements may be made without departing from the spirit and scope of the claims that follow.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
1221103, | |||
1864700, | |||
1960889, | |||
2360051, | |||
2539846, | |||
2701559, | |||
3068868, | |||
3115138, | |||
3125094, | |||
3477437, | |||
3625217, | |||
3683922, | |||
3742954, | |||
3752158, | |||
4128173, | Oct 28 1975 | Peritoneal fluid treatment apparatus, package and method | |
4246899, | Oct 23 1978 | Drainage system for a collection of body fluids | |
5387203, | Jun 28 1993 | Subcutaneous extractor | |
5415182, | May 11 1992 | Boston Scientific Scimed, Inc | Multiple needle biopsy instrument |
5886003, | Mar 07 1997 | Eli Lilly and Company | Methods of treating or ameliorating the symptoms of venomous bites and stings |
7758518, | Jun 08 2001 | Roche Diabetes Care, Inc | Devices and methods for expression of bodily fluids from an incision |
7841991, | May 17 1996 | Roche Diabetes Care, Inc | Methods and apparatus for expressing body fluid from an incision |
7931651, | Nov 17 2006 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | External fixation assembly and method of use |
8062272, | May 21 2004 | Smith & Nephew, Inc | Flexible reduced pressure treatment appliance |
20020077584, | |||
20030069553, | |||
20040078063, | |||
20050085769, | |||
20070270710, | |||
20080097154, | |||
20080103361, | |||
20080281156, | |||
20080306436, | |||
20080306456, | |||
20120226192, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Date | Maintenance Fee Events |
May 15 2017 | M3551: Payment of Maintenance Fee, 4th Year, Micro Entity. |
Dec 06 2021 | REM: Maintenance Fee Reminder Mailed. |
May 23 2022 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Apr 15 2017 | 4 years fee payment window open |
Oct 15 2017 | 6 months grace period start (w surcharge) |
Apr 15 2018 | patent expiry (for year 4) |
Apr 15 2020 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 15 2021 | 8 years fee payment window open |
Oct 15 2021 | 6 months grace period start (w surcharge) |
Apr 15 2022 | patent expiry (for year 8) |
Apr 15 2024 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 15 2025 | 12 years fee payment window open |
Oct 15 2025 | 6 months grace period start (w surcharge) |
Apr 15 2026 | patent expiry (for year 12) |
Apr 15 2028 | 2 years to revive unintentionally abandoned end. (for year 12) |